
Sign up to save your podcasts
Or


Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).
By Chad P. Bown4.8
313313 ratings
Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).

4,137 Listeners

1,967 Listeners

353 Listeners

2,447 Listeners

604 Listeners

101 Listeners

608 Listeners

207 Listeners

717 Listeners

145 Listeners

15,950 Listeners

269 Listeners

348 Listeners

469 Listeners

139 Listeners